Investing

Kauvery Hospital invests in Lifesigns Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.  The new funds, based on a press statement, will "advance Lifesigns’ AI and predictive algorithm capabilities." The company offers an AI-powered remote patient monitoring system that provides alerts and predictive insights.   Lifesigns is now gearing for its next fundraising, where it plans to launch a new product and introduce expansion initiatives.  AI-powered sleep apnoea app now prescribed at major Korean hospital Seoul National University Bundang Hospital is the first among hospitals in South Korea to prescribe an AI-powered mobile application for diagnosing sleep apnoea.  The diagnostic support tool called Apnotrack by medical AI company Asleep records a user's breathing and then uses AI to assess for sleep apnoea.  Asleep claims its app to have comparable performance with at-home polysomnography tests.  Apnotrack received an innovative medical device designation from the South Korean government in 2023 and was approved as a Class II medical device by the Ministry of Food and Drug Safety last year.  TriNetX launches JV with Fujitsu in Japan Global health research network TriNetX has partnered with Fujitsu to launch a joint venture in Japan. The JV, according to a press release, will provide healthcare researchers and pharmaceutical companies in Japan with secure access to big medical and health datasets.  TriNetX runs a self-service data exploration platform for clinical researchers, featuring over 200 million patient records. Its integration with Fujitsu's cloud-based healthcare platform will "create an environment where Japanese medical data, previously underutilised, can be efficiently leveraged for clinical research," said Tatsuki Araki, head of Fujitsu's Healthy Living division.

The company will use the funds to scale its technology, expand into new biomarker applications, and advance real-time hydration and metabolic health monitoring.

Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.

The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.

Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.

GC Wealth is aimed at founders and entrepreneurs within GC Famiglia's global community of entrepreneurs and CEOs connected to General Catalyst.  

The collaboration will provide funding, resources and market access to startups developing healthcare technologies expanding into the United States market from the U.K.

The virtual opioid use disorder company reached profitability in Q4 2024, and expanded its team with the appointments of a chief operating officer and chief financial officer.

The Series C raise comes less than a year after the company secured $50 million in a Series B funding round.

Hone Health completes a $33 million Series A funding round, and Aligned Marketplace raises $11 million in seed funding.